118 related articles for article (PubMed ID: 3419540)
1. Central serotonergic alterations in deoxycorticosterone acetate/NaCl (DOCA/NaCl)-induced hypertension.
Dawson R; Nagamhama S; Oparil S
Neuropharmacology; 1988 Apr; 27(4):417-26. PubMed ID: 3419540
[TBL] [Abstract][Full Text] [Related]
2. Enhanced depressor effect of muscimol in the DOCA/NaCl hypertensive rat: evidence for altered GABAergic activity in brain.
Nagahama S; Dawson R; Oparil S
Proc Soc Exp Biol Med; 1985 Nov; 180(2):277-83. PubMed ID: 4048165
[TBL] [Abstract][Full Text] [Related]
3. Blunted responsiveness of posterior hypothalamic norepinephrine to quinpirole in DOCA/NaCl hypertensive rats.
Chen YF; Jin HK; Gist R; Oparil S
Brain Res Bull; 1987 Apr; 18(4):563-8. PubMed ID: 2440528
[TBL] [Abstract][Full Text] [Related]
4. Arterial 5-hydroxytryptamine transporter function is impaired in deoxycorticosterone acetate and Nomega-nitro-L-arginine but not spontaneously hypertensive rats.
Ni W; Lookingland K; Watts SW
Hypertension; 2006 Jul; 48(1):134-40. PubMed ID: 16754787
[TBL] [Abstract][Full Text] [Related]
5. Altered responsiveness of regional brain dopamine and DOPAC levels to systemic administration of quinpirole, a dopamine D2 agonist, in DOCA/NaCl-hypertensive rats.
Chen YF; Jin HK; Gist R; Oparil S
Brain Res; 1987 Jun; 413(1):15-22. PubMed ID: 2954616
[TBL] [Abstract][Full Text] [Related]
6. Enhanced depressor effect of bromocriptine in the DOCA/NaCl hypertensive rat.
Nagahama S; Chen YF; Oparil S
Am J Physiol; 1985 Jul; 249(1 Pt 2):H64-70. PubMed ID: 2861750
[TBL] [Abstract][Full Text] [Related]
7. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
Chen YF; Jin HK; Paul R; Nagahama S
J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976
[TBL] [Abstract][Full Text] [Related]
8. Hyperresponsiveness of monoaminergic mechanisms in DOCA/NaCl hypertensive rats.
Chen YF; Nagahama S; Winternitz SR; Oparil S
Am J Physiol; 1985 Jul; 249(1 Pt 2):H71-9. PubMed ID: 4014487
[TBL] [Abstract][Full Text] [Related]
9. Chronic dietary administration of tryptophan prevents the development of deoxycorticosterone acetate salt induced hypertension in rats.
Fregly MJ; Lockley OE; van der Voort J; Sumners C; Henley WN
Can J Physiol Pharmacol; 1987 May; 65(5):753-64. PubMed ID: 3621037
[TBL] [Abstract][Full Text] [Related]
10. Altered renal alpha-adrenoceptor density induced by prolonged NaCl and DOCA administration in spontaneously hypertensive rats.
Sánchez A; Lara B; Sáiz J
J Cardiovasc Pharmacol; 1990 Jun; 15(6):857-61. PubMed ID: 1694906
[TBL] [Abstract][Full Text] [Related]
11. Enhanced induction of gastric carcinogenesis by N-methyl-N'-nitro-N-nitrosoguanidine in deoxycorticosterone acetate-NaCl hypertensive rats and its inhibition by potassium chloride.
Tatsuta M; Iishi H; Baba M; Taniguchi H
Cancer Res; 1991 Jun; 51(11):2863-6. PubMed ID: 2032226
[TBL] [Abstract][Full Text] [Related]
12. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats.
Watts SW; Fink GD
Am J Physiol; 1999 Mar; 276(3):H944-52. PubMed ID: 10070078
[TBL] [Abstract][Full Text] [Related]
13. Plasma catecholamines, noradrenaline metabolism and vascular response in desoxycorticosterone acetate hypertension of rats.
Rascher W; Schömig A; Dietz R; Weber J; Gross F
Eur J Pharmacol; 1981 Nov; 75(4):255-63. PubMed ID: 7318911
[TBL] [Abstract][Full Text] [Related]
14. Enhanced response to the inhibitory action of LY171555, a dopamine D2-agonist, on in vivo striatal dopamine release in DOCA/NaCl-hypertensive rats.
Chen YF; Oparil S
Brain Res; 1987 Jan; 400(2):225-31. PubMed ID: 2949797
[TBL] [Abstract][Full Text] [Related]
15. Abnormal regulation of the sympathoadrenal system in deoxycorticosterone acetate-salt hypertensive rats.
de Champlain J; Bouvier M; Drolet G
Can J Physiol Pharmacol; 1987 Aug; 65(8):1605-14. PubMed ID: 2825939
[TBL] [Abstract][Full Text] [Related]
16. Deoxycorticosterone acetate-salt rats: hypertension and sympathoexcitation driven by increased NaCl levels.
O'Donaughy TL; Brooks VL
Hypertension; 2006 Apr; 47(4):680-5. PubMed ID: 16520400
[TBL] [Abstract][Full Text] [Related]
17. Separate hemodynamic roles for chloride and sodium in deoxycorticosterone acetate-salt hypertension.
Passmore JC; Jimenez AE
Proc Soc Exp Biol Med; 1990 Jul; 194(3):283-8. PubMed ID: 2356192
[TBL] [Abstract][Full Text] [Related]
18. Increased vasopressinergic activity following DOCA administration in the rat.
Chen YF; Lindheimer MD; Oparil S
Brain Res Bull; 1986 Jan; 16(1):93-8. PubMed ID: 3955390
[TBL] [Abstract][Full Text] [Related]
19. Alterations in noradrenergic physiological characteristics with DOCA-hypertension: interaction between norepinephrine and GABA in rat lateral hypothalamus.
Sessler FM; Mah EJ; Grady SM
Brain Res; 1993 Jun; 613(2):259-68. PubMed ID: 8186973
[TBL] [Abstract][Full Text] [Related]
20. Changes in vascular vasopressin receptors and responsiveness in DOCA/NaCl-treated rats.
Smith CD; Pearlmutter F; Szkrybalo M; Katovich MJ
Clin Exp Hypertens A; 1988; 10(4):629-47. PubMed ID: 2968870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
